1-20 of 65
Authors: Richard A Feelders
Journal Article
Serum 5-Hydroxyindoleacetic Acid Measurements for the Diagnosis and Follow-up of Carcinoid Syndrome Open Access
The Journal of Clinical Endocrinology & Metabolism, dgaf263, https://doi.org/10.1210/clinem/dgaf263
Published: 02 May 2025
Journal Article
Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous Cushing's syndrome: a position statement Get access
European Journal of Endocrinology, Volume 192, Issue 3, March 2025, Pages R17–R27, https://doi.org/10.1093/ejendo/lvaf017
Published: 20 February 2025
Journal Article
Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol Open Access
Journal of the Endocrine Society, Volume 9, Issue 1, January 2025, bvae201, https://doi.org/10.1210/jendso/bvae201
Published: 12 November 2024
Journal Article
How to manage Cushing's disease after failed primary pituitary surgery Get access
European Journal of Endocrinology, Volume 191, Issue 3, September 2024, Pages R37–R54, https://doi.org/10.1093/ejendo/lvae110
Published: 14 September 2024
Journal Article
PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas Open Access
European Journal of Endocrinology, Volume 191, Issue 3, September 2024, Pages 345–353, https://doi.org/10.1093/ejendo/lvae108
Published: 22 August 2024
Journal Article
Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 6, June 2024, Pages e1424–e1433, https://doi.org/10.1210/clinem/dgae151
Published: 22 March 2024
Journal Article
Approach to the Patient: Insulinoma Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 4, April 2024, Pages 1109–1118, https://doi.org/10.1210/clinem/dgad641
Published: 31 October 2023
Journal Article
THU035 Impact Of Surgery Or Medical Treatment With The Selective Glucocorticoid Receptor Modulator Relacorilant On Hypercoagulopathy In Patients With Cushing Syndrome Open Access
Journal of the Endocrine Society, Volume 7, Issue Supplement_1, October-November 2023, bvad114.1115, https://doi.org/10.1210/jendso/bvad114.1115
Published: 05 October 2023
Journal Article
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome Get access
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages 395–406, https://doi.org/10.1093/ejendo/lvad008
Published: 07 February 2023
Journal Article
Dissecting the In Vitro Efficacy of Octreotide and Cabergoline in GH- and GH/PRL-Secreting Pituitary Tumors Free
The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 5, May 2023, Pages e98–e109, https://doi.org/10.1210/clinem/dgac675
Published: 22 November 2022
Journal Article
PMON160 Improvements in Clinical Signs of Hypercortisolism and Quality of Life According to Urinary and Late-Night Salivary Cortisol Levels in Patients with Cushing's Disease Treated with Osilodrostat Open Access
Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Page A545, https://doi.org/10.1210/jendso/bvac150.1133
Published: 01 November 2022
Journal Article
OR27-3 Long-Term Results from the Phase III LINC 4 Study: Osilodrostat Maintained Normal Mean Urinary Free Cortisol in Patients with Cushing's Disease, with a Favorable Safety Profile Open Access
Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Pages A525–A526, https://doi.org/10.1210/jendso/bvac150.1094
Published: 01 November 2022
Journal Article
PMON148 ACQUIRED TEMOZOLOMIDE RESISTANCE IN CORTICOTROPE PITUITARY TUMOR CELLS Open Access
Journal of the Endocrine Society, Volume 6, Issue Supplement_1, November-December 2022, Page A541, https://doi.org/10.1210/jendso/bvac150.1125
Published: 01 November 2022
Journal Article
Peptide Receptor Radionuclide Therapy Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 12, December 2022, Pages 3199–3208, https://doi.org/10.1210/clinem/dgac574
Published: 05 October 2022
Journal Article
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension Open Access
European Journal of Endocrinology, Volume 187, Issue 4, Oct 2022, Pages 531–541, https://doi.org/10.1530/EJE-22-0317
Published: 16 September 2022
Journal Article
Approach to the Patient: Diagnosis of Cushing Syndrome Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 11, November 2022, Pages 3162–3174, https://doi.org/10.1210/clinem/dgac492
Published: 29 August 2022
Journal Article
Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation study Open Access
European Journal of Endocrinology, Volume 187, Issue 3, Sep 2022, Pages 399–411, https://doi.org/10.1530/EJE-22-0339
Published: 21 July 2022
Journal Article
Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients Get access
European Journal of Endocrinology, Volume 187, Issue 1, Jul 2022, Pages 209–217, https://doi.org/10.1530/EJE-22-0023
Published: 07 June 2022
Journal Article
Randomized Trial of Osilodrostat for the Treatment of Cushing Disease Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 7, July 2022, Pages e2882–e2895, https://doi.org/10.1210/clinem/dgac178
Published: 23 March 2022
Journal Article
Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women Open Access
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 5, May 2022, Pages e1969–e1975, https://doi.org/10.1210/clinem/dgac001
Published: 06 January 2022
